ImmuCell Corporation (ICCC) financial statements (2022 and earlier)

Company profile

Business Address 56 EVERGREEN DR
PORTLAND, ME 04103
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,1857,9468,7742,5213,79910,6246,037
Cash and cash equivalents10,1856,9506,2932,5213,7995,1501,573
Short-term investments 9962,481  5,4744,464
Receivables2,6941,8481,6379491,358996754
Inventory, net of allowances, customer advances and progress billings3,0902,0932,5182,3322,0502,127870
Inventory3,0902,0932,5182,3322,0502,127870
Prepaid expense 253218143131127183
Other undisclosed current assets295174147717047528
Total current assets:16,26512,15713,1896,4217,50714,3487,873
Noncurrent Assets
Operating lease, right-of-use asset1,1091,220 
Property, plant and equipment26,89426,75525,26626,02826,0709,8465,719
Long-term investments and receivables      487
Long-term investments      487
Intangible assets, net (including goodwill)172191210229248267 
Goodwill969696969696 
Intangible assets, net (excluding goodwill)7696115134153172 
Derivative instruments and hedges   40   
Other noncurrent assets2626271313450
Other undisclosed noncurrent assets    473201472
Total noncurrent assets:28,20128,19325,50326,31026,79210,3496,727
TOTAL ASSETS:44,46640,35038,69232,73134,29924,69714,601
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,6141,3501,2211,2211,7231,892662
Accounts payable7456025726041,2221,507201
Accrued liabilities828515193648356
Employee-related liabilities586525400358255200243
Taxes payable2      
Other undisclosed accounts payable and accrued liabilities19913798165182102162
Debt812760   133136
Deferred compensation liability      20
Deferred revenue and credits2434 
Other undisclosed current liabilities1081011,2751,344317  
Total current liabilities:2,5342,2112,4952,5652,0642,059818
Noncurrent Liabilities
Long-term debt and lease obligation9,3549,8727,1478,4218,6392,8793,091
Long-term debt, excluding current maturities8,3278,7377,1478,4218,6392,8793,091
Operating lease, liability1,0271,135 
Liabilities, other than long-term debt  59    
Derivative instruments and hedges, liabilities  59    
Other undisclosed noncurrent liabilities(1,027)(1,135)  13779
Total noncurrent liabilities:9,3549,8727,2058,4218,6402,9163,169
Total liabilities:11,88912,0839,70110,98610,7044,9753,987
Stockholders' equity
Stockholders' equity attributable to parent32,57728,26628,99121,74423,59519,72210,614
Common stock781730730566566504326
Treasury stock, value(158)(175)(188)(205)(408)(432)(451)
Additional paid in capital35,69231,37231,13222,69622,45818,52610,150
Accumulated other comprehensive income (loss)  (44)30(1)(24)(50)
Retained earnings (accumulated deficit)(3,739)(3,660)(2,638)(1,343)9791,147639
Total stockholders' equity:32,57728,26628,99121,74423,59519,72210,614
TOTAL LIABILITIES AND EQUITY:44,46640,35038,69232,73134,29924,69714,601

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues19,24315,34213,72310,98610,4319,54410,229
Revenue, net10,4319,54410,229
Cost of revenue
(Cost of Goods and Services Sold)
(10,587)(8,479)(6,983)(5,792)(5,210)(4,123)(3,978)
Gross profit:8,6566,8636,7405,1945,2215,4216,251
Operating expenses(8,399)(8,243)(7,694)(6,640)(5,464)(4,530)(4,129)
Operating income (loss):257(1,380)(954)(1,447)(243)8902,122
Nonoperating income (expense)(327)348(314)(413)(196)(132)(6)
Investment income, nonoperating      (6)
Other nonoperating income (expense)(327)348(314)(413)(196)(132) 
Interest and debt expense(314)(8)(432)(428)(219)(162)(80)
Income (loss) from continuing operations before equity method investments, income taxes:(383)(1,040)(1,699)(2,288)(657)5972,036
Other undisclosed income from continuing operations before income taxes314843242821916227
Income (loss) from continuing operations before income taxes:(69)(1,032)(1,267)(1,860)(438)7582,064
Income tax expense (benefit)(9)10(28)(462)270(250)(850)
Net income (loss):(78)(1,022)(1,296)(2,322)(168)5081,213
Net income attributable to noncontrolling interest78      
Other undisclosed net loss attributable to parent(78)      
Net income (loss) available to common stockholders, diluted:(78)(1,022)(1,296)(2,322)(168)5081,213

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(78)(1,022)(1,296)(2,322)(168)5081,213
Other comprehensive income (loss) 44(74)312326(27)
Comprehensive income (loss):(78)(978)(1,370)(2,291)(145)5351,186
Comprehensive income, net of tax, attributable to noncontrolling interest78      
Other undisclosed comprehensive loss, net of tax, attributable to parent(78)      
Comprehensive income (loss), net of tax, attributable to parent:(78)(978)(1,370)(2,291)(145)5351,186

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: